The good, the bad and the ugly - novel synoptic variables in the personalisation of colon cancer treatment

Purpose Standardised international reporting for colon cancer (CC) provides foundational prognostic data. However, novel histopathological variables—tumour-infiltrating lymphocytes (TILs), tumour budding (TB), and poorly differentiated clusters (PDCs)—offer superior insights into tumour biology. This review evaluates their clinical utility in risk stratification and treatment personalisation for stage I–III CC. Methods A comprehensive literature review was conducted to evaluate the prognostic and predictive value of TILs, TB, and PDCs in stage I–III CC. Results High TIL density is associated with improved oncological endpoints in stage II–III disease. Crucially, in stage III disease, a high Immunoscore predicts a survival benefit from extending adjuvant chemotherapy from 3 to 6 months, whereas low TIL density in mismatch repair deficient may identify a high-risk patient cohort that is otherwise overlooked. Conversely, high-grade (HG) TB and PDCs are potent independent markers of poor prognosis, outperforming traditional histopathological variables in multiple studies. In stage I disease, HG TB/PDCs significantly elevate the risk of lymph node metastasis, providing a critical metric when considering segmental resection after malignant polyp removal. In the stage II/III cohort, HG TB/PDCs correlate with diminished disease-free and overall survival, with emerging data suggesting these variables may identify phenotypes resistant to standard fluoropyrimidine monotherapy. Conclusion TILs, TB, and PDCs provide vital, biology-focused prognostic and predictive data using cost-effective, routinely stained sections of tumour. Incorporating these variables into standard synoptic reporting and clinical guidelines will refine risk stratification and advance precision oncology in CC management.

Authors

Institutions

Publication Details

Journal
International Journal of Colorectal Disease
Published
2026-11-18
DOI
https://doi.org/10.1007/s00384-026-05265-w
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The good, the bad and the ugly - novel synoptic variables in the personalisation of colon cancer treatment

Ryash Vather, Tarik Sammour, Matthew Watson, Zachary Bunjo et al.
International Journal of Colorectal Disease
Colorectal Cancer Surgical Treatments
article

The good, the bad and the ugly - novel synoptic variables in the personalisation of colon cancer treatment

Ryash Vather, Tarik Sammour, Matthew Watson, Zachary Bunjo, Tharani Krishnan, Sean Davis, Andrew Ruszkiewicz
article en

Abstract

Purpose Standardised international reporting for colon cancer (CC) provides foundational prognostic data. However, novel histopathological variables—tumour-infiltrating lymphocytes (TILs), tumour budding (TB), and poorly differentiated clusters (PDCs)—offer superior insights into tumour biology. This review evaluates their clinical utility in risk stratification and treatment personalisation for stage I–III CC. Methods A comprehensive literature review was conducted to evaluate the prognostic and predictive value of TILs, TB, and PDCs in stage I–III CC. Results High TIL density is associated with improved oncological endpoints in stage II–III disease. Crucially, in stage III disease, a high Immunoscore predicts a survival benefit from extending adjuvant chemotherapy from 3 to 6 months, whereas low TIL density in mismatch repair deficient may identify a high-risk patient cohort that is otherwise overlooked. Conversely, high-grade (HG) TB and PDCs are potent independent markers of poor prognosis, outperforming traditional histopathological variables in multiple studies. In stage I disease, HG TB/PDCs significantly elevate the risk of lymph node metastasis, providing a critical metric when considering segmental resection after malignant polyp removal. In the stage II/III cohort, HG TB/PDCs correlate with diminished disease-free and overall survival, with emerging data suggesting these variables may identify phenotypes resistant to standard fluoropyrimidine monotherapy. Conclusion TILs, TB, and PDCs provide vital, biology-focused prognostic and predictive data using cost-effective, routinely stained sections of tumour. Incorporating these variables into standard synoptic reporting and clinical guidelines will refine risk stratification and advance precision oncology in CC management.

International Journal of Colorectal Disease
South Australia Pathology (AU), Royal Adelaide Hospital (AU), Flinders University (AU), Flinders Medical Centre (AU), Adelaide University (AU), The University of Adelaide (AU)
Good health and well-being
Colorectal Cancer Surgical Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon